Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exosome-based OCS Scores for Predicting Ovarian Cancer Recurrence: a Prospective Multicenter Observational Cohort

NCT06558019 is registered in ClinicalTrials.gov with Lei Li as lead sponsor.

NCT NCT06558019
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06558019 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exosome-based OCS Scores for Predicting Ovarian Cancer Recurrence: a Prospective Multicenter Observational Cohort
Lead sponsor
Lei Li
Phase
Observational
Overall status
Not yet recruiting
Start date
October 1, 2024
Completion date
December 31, 2026
Enrollment
509 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer